As a defining fashion element of the nova Series, HUAWEI nova 13 Series elevates its signature Super Star Orbit Ring camera ...

Global trust and corporate service market was valued at US$ 13.3 billion in 2023 and is projected to surpass market valuation of US$ 19.2 billion by 2032 at a CAGR of 4.2% during the forecast period ...

Global polar travel market was valued at US$ 953.7 million in 2023 and is projected to reach a valuation of US$ 2,300.8 million by 2032 at a CAGR of 10.28% during the forecast period 2024–2032.

HONG KONG, Dec. 14, 2024 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces that CNOOC Energy Holdings U.S.A. Inc., a US-based ...

TORONTO and KNOXVILLE, Tenn., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR), a leading solar energy solutions provider focused on the ...

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has increased its ownership interest in Brit Limited to 100% from 86.2% ...

SPRINGFIELD, N.J., Dec. 13, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Village Super Market, Inc. (NSD-VLGEA) declared quarterly cash dividends of $0.25 per Class A common share and $0.1625 ...

Banco Comercial Português, S.A. informs about the upgrade of senior debt ratings by Fitch Ratings ...

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in ...

LAKE FOREST, Calif, Dec. 13, 2024 (GLOBE NEWSWIRE) -- ATIF Holdings Limited (NASDAQ: ATIF, the "Company" or "ATIF") announced today that the Company plans on changing its Nasdaq ticker symbol from ...

NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX®), which will become effective prior to ...

UNLOXCYT is the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc.